V-Wave Secures $28M in Financing
Medical device company V-Wave has scooped up $28 million in Series B financing.
The funding — which includes new investors Johnson & Johnson Innovation, TriVentures, Pura Vida Investments and BioStar Ventures — will support clinical evaluation and development, as well as a manufacturing scale-up of the company’s minimally invasive device for chronic symptomatic heart failure.
The device is implanted in the atrial septum and regulates left atrial pressure by shunting excess blood volume away from the left ventricle.
Existing investors BRM Group, Pontifax and Edwards Lifesciences also participated in the financing. — Michael Cipriano